Literature DB >> 30166343

Uropathogenic Escherichia coli invades bladder epithelial cells by activating kinase networks in host cells.

Wan-Ju Kim1, Allyson E Shea1, Joon-Hyung Kim1, Yehia Daaka2.   

Abstract

Uropathogenic Escherichia coli (UPEC) is the causative bacterium in most urinary tract infections (UTIs). UPEC cells adhere to and invade bladder epithelial cells (BECs) and cause uropathogenicity. Invading UPEC cells may encounter one of several fates, including degradation in the lysosome, expulsion to the extracellular milieu for clearance, or survival as an intracellular bacterial community and quiescent intracellular reservoir that can cause later infections. Here we considered the possibility that UPEC cells secrete factors that activate specific host cell signaling networks to facilitate the UPEC invasion of BECs. Using GFP-based reporters and Western blot analysis, we found that the representative human cystitis isolate E. coli UTI89 and its derivative UTI89ΔFimH, which does not bind to BECs, equally activate phosphatidylinositol 4,5-bisphosphate 3-OH kinase (PI3K), Akt kinase, and mTOR complex (mTORC) 1 and 2 in BECs. We also found that conditioned medium taken from UTI89 and UTI89ΔFimH cultures similarly activates epidermal growth factor receptor (EGFR), PI3K, Akt, and mTORC and that inhibition of EGFR and mTORC2, but not mTORC1, abrogates UTI89 invasion in vitro and in animal models of UTI. Our results reveal a key molecular mechanism of UPEC invasion and the host cells it targets, insights that may have therapeutic utility for managing the ever-increasing number of persistent and chronic UTIs.
© 2018 Kim et al.

Entities:  

Keywords:  bacterial pathogenesis; conditioned medium; epidermal growth factor receptor (EGFR); host–pathogen interaction; secretion; signal transduction; urinary tract infection; uropathogenic E. coli

Mesh:

Substances:

Year:  2018        PMID: 30166343      PMCID: PMC6200948          DOI: 10.1074/jbc.RA118.003499

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

Review 1.  Toll-like receptors: linking innate and adaptive immunity.

Authors:  Chandrashekhar Pasare; Ruslan Medzhitov
Journal:  Adv Exp Med Biol       Date:  2005       Impact factor: 2.622

2.  PtdIns(3,4,5)P3-Dependent Activation of the mTORC2 Kinase Complex.

Authors:  Pengda Liu; Wenjian Gan; Y Rebecca Chin; Kohei Ogura; Jianping Guo; Jinfang Zhang; Bin Wang; John Blenis; Lewis C Cantley; Alex Toker; Bing Su; Wenyi Wei
Journal:  Cancer Discov       Date:  2015-08-20       Impact factor: 39.397

Review 3.  Cargo adaptors: structures illuminate mechanisms regulating vesicle biogenesis.

Authors:  Jon E Paczkowski; Brian C Richardson; J Christopher Fromme
Journal:  Trends Cell Biol       Date:  2015-03-17       Impact factor: 20.808

4.  Involvement of the epidermal growth factor receptor in the invasion of cultured mammalian cells by Salmonella typhimurium.

Authors:  J E Galán; J Pace; M J Hayman
Journal:  Nature       Date:  1992-06-18       Impact factor: 49.962

Review 5.  G proteins in cancer: the prostate cancer paradigm.

Authors:  Yehia Daaka
Journal:  Sci STKE       Date:  2004-01-13

6.  Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors.

Authors:  H Daub; F U Weiss; C Wallasch; A Ullrich
Journal:  Nature       Date:  1996-02-08       Impact factor: 49.962

Review 7.  Epidemiology of urinary tract infections: incidence, morbidity, and economic costs.

Authors:  Betsy Foxman
Journal:  Am J Med       Date:  2002-07-08       Impact factor: 4.965

8.  In vitro binding of type 1-fimbriated Escherichia coli to uroplakins Ia and Ib: relation to urinary tract infections.

Authors:  X R Wu; T T Sun; J J Medina
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

9.  Dynamin2- and endothelial nitric oxide synthase-regulated invasion of bladder epithelial cells by uropathogenic Escherichia coli.

Authors:  Zhimin Wang; Ceba Humphrey; Nicole Frilot; Gaofeng Wang; Zhongzhen Nie; Nader H Moniri; Yehia Daaka
Journal:  J Cell Biol       Date:  2011-01-10       Impact factor: 10.539

10.  Transient microbiota exposures activate dormant Escherichia coli infection in the bladder and drive severe outcomes of recurrent disease.

Authors:  Nicole M Gilbert; Valerie P O'Brien; Amanda L Lewis
Journal:  PLoS Pathog       Date:  2017-03-30       Impact factor: 6.823

View more
  3 in total

1.  Dissecting and Evaluating the Therapeutic Targets of Coptis Chinensis Franch in the Treatment of Urinary Tract Infections Induced by Escherichia coli.

Authors:  Zhenglin Chang; Jinhu Zhang; Min Lei; Zheng Jiang; Xiangkun Wu; Yapeng Huang; Zhican He; Yuyan Zhang; Shujue Li; Xiaolu Duan; Wenqi Wu
Journal:  Front Pharmacol       Date:  2022-01-12       Impact factor: 5.810

Review 2.  The immune responses to different Uropathogens call individual interventions for bladder infection.

Authors:  Linlong Li; Yangyang Li; Jiali Yang; Xiang Xie; Huan Chen
Journal:  Front Immunol       Date:  2022-08-23       Impact factor: 8.786

Review 3.  The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications.

Authors:  Douglas B Kell; Etheresia Pretorius
Journal:  Biochem J       Date:  2022-08-31       Impact factor: 3.766

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.